Training and Resources

GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)

GARDASIL® 9 is indicated for active immunisation of individuals from the age of 9 years against the following HPV diseases: Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine HPV types; Genital warts (Condyloma acuminata) caused by specific HPV types.

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

• Healthcare Professional Resources
• School Immuniser Resources
• Pharmacist Resources

 

Human Papillomavirus: Infographic for HCPs in primary care

Download

 

A nurse immunisers guide to HPV vaccination

Download

HPV Vaccination Best Practice Guides

 

What do I need to know?

Download

 

What is the impact of HPV vaccination in the UK?

Download

 

How can primary care improve HPV vaccination uptake?

Download

 

What can your practice do to increase HPV vaccination uptake?

Download

 

What are the benefits of HPV vaccination?

Download

 

Digital Schools Poster

Available to download for free – this digital poster is to help School Immunisers raise awareness of HPV and HPV vaccination for boys and girls in the UK

Download

Discussion guide for pharmacists

Available to download for free- This discussion guide is designed to help address your patients’ questions regarding HPV vaccination.

Download

Supporting documentation

GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine) (Recombinant, adsorbed)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website